The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Diseases|Breast Neoplasms
Interventions: DRUG: Palbociclib|DRUG: Placebo oral capsule|DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Paclitaxel
Sponsor: Zhejiang Cancer Hospital